Abstracts from 2014 through the most recent CROI can be viewed in this searchable database once they have been presented at the conference. Abstract Contents: The searchable database includes abstract text as submitted by the authors prior to CROI. Study data might be updated during the presentation at CROI. Please refer to the electronic poster or webcast for updates. Searching the Abstract Database: Enter the criteria below and click the “Search” button. After the search has been entered, the results will appear below the search form.

CROI conference materials (eg, the conference program, Abstract eBook, electronic posters, CROI logo, etc) are protected by copyright. Permission to replicate or reproduce these elements, in whole or in part, must be obtained from the CROI Conference Manager, the International Antiviral Society-USA (IAS-USA). Study data (including figures within abstracts or electronic posters) are the property of the study authors. Permission to use data and figures cannot be given by IAS–USA unless it is for regulatory reasons. For more information, please email CROIabstracts@iasusa.org.

Search Results

1277 Results

596 – Cannabis Use Is Associated With Reduced Brain Integrity in Persons With HIV

Background Cannabis (CB) use is increasing nationwide due to legal changes and commercialization. People with HIV (PWH) are more likely to use CB versus people without HIV (PWoH). Data on the effects of CB use on brain structure and cognition in PWH are mixed, with few studies including measures of structural brain integrity. Methods In…

623 – Hypertension: A Major Factor in Low Verbal Fluency Among People Aged 50+ Living With HIV in Senegal

Background Decline in verbal fluency, observed both in aging and HIV infection, is associated with reduced quality of life. The association of cardiometabolic diseases with verbal fluency is well described in Western Countries, not in Sub-Saharan Africa, especially in older people living with HIV (PLWH). This study aims to identify the factors associated with verbal…

603 – Cognitive Intra-Individual Variability Predicts IADL Function in the Women’s Interagency HIV Study

Background Cognitive intra-individual variability (IIV) refers to the variation observed in cognitive performance when various cognitive tests are administered within the same person (i.e., dispersion). In people with HIV, greater cognitive IIV has been associated with poorer cognitive performance and decline over time, cortical brain atrophy, and increased mortality risk. In this study, we calculated…

631 – HIV-Infected Microglia Drive Transcriptional and Metabolic Changes in Complex Human Brain Organoids

Background HIV enters the central nervous system early after infection which can result in HIV-associated neurocognitive disorder (HAND), affecting as many as 50% of people living with HIV (PWH). HIV-induced neuroinflammation plays a critical role in HAND. Here, we investigated the impact of HIV infection on brain inflammation and metabolism using an advanced 3D human brain…

620 – No Impact on the CNS After Switching to Dolutegravir/Lamivudine From a 3-Drug Regimen

Background Dual-drug therapy with dolutegravir/lamivudine (DTG/3TC) is effective in achieving viral suppression in the blood, but its impact on HIV infection in the central nervous system (CNS) remains insufficiently explored. In this study, we aimed to investigate its effect in the CNS through assessment of cerebrospinal fluid (CSF) in individuals switching to DTG/3TC from a…

613 – Epigenetic Modifications Predictive of Cognitive Frailty in Cocaine-Using People Living With HIV

Background People living with HIV (PLWH) are disproportionately burdened by neurocognitive impairment (NCI) and physical frailty. Cognitive frailty, the combination of both, results in poorer outcomes than physical frailty or NCI alone. While epigenetic modifications are linked to each of these conditions separately, cognitive frailty remains understudied, and HIV and cocaine use may worsen outcomes.…

627 – HIV Transcripts in Blood May Identify Patients at Lower Risk of Brain Injury in Cure Research

Background Suppressed HIV patients’ PBMC have residual cell associated HIV-1 RNA transcripts (HRT). Elevated HRT, despite ART, associate with viral blips and with brain injury. Most cure studies aim to reduce HIV DNA reservoir but may require initial viral reactivation, risking brain injury from viral blips due to reservoir activity. Under ART, blips are believed…

606 – Single-Nucleus Multiomics Reveals Dysfunction in Multiple Glial Cell Types in Brain Tissue of PWH

Background Central nervous system (CNS) dysfunction is a recognized complication in some people with HIV (PWH). As part of SCORCH (a large-scale, consortium-wide effort examining transcriptional and epigenetic alterations in the brains of PWH), we aim to identify key cell populations and pathways affected by HIV that may be targeted in therapies for HIV-associated CNS…

614 – Differential Effects of CB2 Agonism on HIV Replication and Inflammatory Activation in Myeloid Cells

Background Evidence indicates that brain-resident myeloid cells, including perivascular macrophages and microglia, provide a reservoir for HIV infection in the central nervous system (CNS). Data also suggest that the inflammatory activity of these cells is associated with HIV-associated cognitive impairment. We investigated whether cannabinoid receptor (CB) 2 (CB2), an immunomodulatory receptor expressed in myeloid cells,…

597 – Inflammatory Biomarker Profiling to Predict Neuroinflammation and Depression in Adolescents With HIV

Background Despite early antiretroviral therapy (ART), individuals with perinatally acquired HIV often show neuroinflammation and a heightened risk of depression as they approach early adulthood. Longitudinal monitoring of inflammatory markers may provide insights into these outcomes, aiding in the prediction of neuroinflammatory processes and mental health risks. We examined these associations longitudinally in cohorts from…